Tennessee 2025 2025-2026 Regular Session

Tennessee Senate Bill SB0610 Draft / Bill

Filed 01/31/2025

                     
HOUSE BILL 428 
 By Stinnett 
 
SENATE BILL 610 
By Massey 
 
 
SB0610 
001606 
- 1 - 
 
AN ACT to amend Tennessee Code Annotated, Title 56 
and Title 71, relative to continuous glucose 
monitoring. 
 
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: 
 SECTION 1.  Tennessee Code Annotated, Title 71, Chapter 5, Part 1, is amended by 
adding the following as a new section: 
 (a)  As used in this section: 
 (1)  "Bureau" means the bureau of TennCare; 
 (2)  "Continuous glucose monitor" or "CGM" means a device that 
automatically and continuously monitors a user's blood glucose levels through 
the use of a sensor on the user's body, and enables the user to read the blood 
glucose level; and 
 (3)  "Enrollee" means an individual enrolled in TennCare. 
 (b)  The bureau shall provide coverage on behalf of an enrollee for a CGM if: 
 (1)  The patient: 
 (A)  Has a diagnosis of Type 1 diabetes mellitus; 
 (B)  Has a diagnosis of gestational diabetes; 
 (C)  Has a history of problematic hypoglycemia; or 
 (D)  Requires the use of insulin; or 
(2)  The patient has a diagnosis of Type 2 diabetes mellitus and the 
patient meets at least one (1) of the following criteria:    
 
 
 	- 2 - 	001606 
 
(A)  Documented hemoglobin A1C greater than or equal to seven 
percent (7%) measured within six (6) months of a request for laboratory 
blood work; 
(B)  Documented frequent hypoglycemia or nocturnal 
hypoglycemia episodes with blood glucose levels of less than fifty 
milligrams per deciliter (50 mg/dl); 
(C)  Documented history of hypoglycemic unawareness; 
(D)  Dawn phenomenon with fasting blood sugars frequently 
exceeding two hundred milligrams per deciliter (200 mg/dl); or 
(E)  History of emergency room visits or hospitalizations related to 
ketoacidosis or hypoglycemia. 
(c)  The mandatory coverage under subsection (b) is required only if the CGM is 
prescribed by or in consultation with an endocrinologist or healthcare practitioner with 
experience in diabetes management who documents that the enrollee meets the criteria 
under subdivision (b)(1) or subdivision (b)(2). 
 SECTION 2.  This act takes effect January 1, 2026, the public welfare requiring it.